Discover groundbreaking research on pulmonary fibrosis and a potential new treatment target that could revolutionize lung ...
Scientists at UCSF identified a key cellular switch that plays a large role in pulmonary fibrosis, and found a way of ...
UVA Health lung researchers are developing a promising approach to detecting patients at risk of interstitial lung disease ...
Abstract: This letter focuses on the flexible tube of a bronchoscope robot used in pulmonary intervention surgery, which is considered as a continuum robot. The dynamics model is proposed based on the ...
Abstract: Histological staining is vital in clinical pathology for visualizing tissue structures. However, these techniques are laborious and time-consuming. Digital virtual staining offers a ...
ACEi therapy initiated in the 5 years prior to IPF diagnosis was independently linked to lower all-cause mortality, suggesting ACEi might act as a disease-modifying agent. Angiotensin-converting ...
STOCKHOLM, SE / ACCESS Newswire / September 30, 2025 / Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today ...
Endeavor BioMedicines Announces Publication of Positive Data from Phase 2a Trial in The Lancet Respiratory Medicine Evaluating taladegib (ENV-101) in Individuals with Idiopathic Pulmonary Fibrosis ...
Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback